PYC Therapeutics Ltd

PYC

Company Profile

  • Business description

    PYC Therapeutics Ltd is a clinical-stage biotechnology company creating a new generation of RNA therapies for patients with genetic diseases. The Group is engaged in drug development and progressing the Company's drug pipeline through preclinical and clinical development. The Company operates in a single business segment comprising the discovery and development of novel RNA therapeutics, with a single geographical location in Australia.

  • Contact

    6 Verdun Street
    Harry Perkins Institute of Medical Research
    Nedlands
    PerthWA6009
    AUS

    T: +61 861510992

    https://www.pyctx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    Employees

    5

Stocks News & Analysis

stocks

This defensive ASX listed REIT offers a 5% yield

Solid outlook underpinned by rent uplifts and development pipeline.
stocks

Chart of the Week: Anthropic’s IPO range sits below our fair value

Our fair value is above the IPO range, but outcomes could differ widely.
stocks

Taking a look at opportunities in gaming shares as the highly anticipated GTA 6 is released

Several gaming shares are trading at a discount to our fair value.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,836.6095.80-1.07%
CAC 408,144.832.00-0.02%
DAX 4025,735.850.39-0.00%
Dow JONES (US)50,198.17561.25-1.11%
FTSE 10010,527.5323.64-0.22%
HKSE22,841.62453.13-1.95%
NASDAQ24,429.88101.500.42%
Nikkei 22559,444.21419.930.71%
NZX 50 Index14,247.2517.04-0.12%
S&P 5007,323.630.000.00%
S&P/ASX 2008,730.4091.40-1.04%
SSE Composite Index3,577.6210.21-0.28%

Market Movers